The Reverse Stock Split is primarily intended to bring the Company into compliance with The Nasdaq Stock Market LLC’s (“Nasdaq”) $1.00 minimum bid price requirement for maintaining its ...

The Reverse Split will legally take effect at 4:01 p.m. Eastern Time, on February 21, 2025. The Company’s common stock will open for trading under a new CUSIP number 3622AW 403 on The Nasdaq ...

The reverse stock split is primarily intended to increase the Company's per share trading price and bring the Company into compliance with the Nasdaq's listing requirement regarding minimum share ...

Karyopharm Therapeutics (NASDAQ:KPTI) will implement a 1-for-15 reverse stock split of the issued shares of its common stock on February 25, 2025. The split is intended to increase the per-share ...

January 2025, the U.S. Securities and Exchange Commission (SEC) approved amendments, both of which are now effective, to The Nasdaq Stock Market ...

The Reverse Stock Split is intended to enable the Company ... Company’s Class A Common Stock for continued listing on The Nasdaq Capital Market (“Nasdaq”). As a result of the Reverse Stock ...

Feb. 13, 2025 /PRNewswire/ -- Cyngn Inc. (the "Company" or "Cyngn") (Nasdaq: CYN) today announced that it will proceed with a 1-for-150 reverse stock split ("Reverse Stock Split") of its ...

BETHESDA, MD, Feb. 20, 2025 (GLOBE NEWSWIRE) -- HWH International Inc. (the “Company”) (NASDAQ: HWH), a purpose-driven lifestyle company, today announced a 1-for-5 reverse stock split of the ...

60 Degrees Pharmaceuticals announces a 1-for-5 reverse stock split to comply with Nasdaq's minimum bid price requirement. 60 Degrees Pharmaceuticals, Inc. has announced a 1-for-5 reverse stock ...

Karyopharm (KPTI) will implement a 1-for-15 reverse stock split of the issued shares of the company’s common stock effective at 5:00 p.m.

HOUSTON, TX / ACCESS Newswire / February 19, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP)("CNS" or the "Company"), a ...

Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new ...